GlassScriptPhysician profile
Benjamin Mccray Taylor
NPI 1235788795
$2,680.70
in general payments reported to CMS, 2019-2025
16 companies · $468 in 2025
The $468 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $86.61 · 2021: $378 · 2022: $667 · 2023: $416 · 2024: $557 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $685.10 | 2021-2025 | Precision7, Simbrinza, Rhopressa |
| Bausch & Lomb Americas INC. | $679.35 | 2022-2025 | Infuse, Biotrue, Vyzulta |
| Coopervision INC. | $279.53 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $213.50 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $147.04 | 2022 | |
| New World Medical,INC. | $124.24 | 2023 | |
| Sun Pharmaceutical Industries INC. | $112.53 | 2019-2021 | |
| Notal Vision, INC. | $100.33 | 2022-2024 | Foresee Home |
| Allergan, INC. | $98.48 | 2022 | |
| Dompe US, INC. | $84.22 | 2024 | Oxervate |
| Oyster Point Pharma, INC. | $47.18 | 2022 | |
| Ani Pharmaceuticals, INC. | $40.86 | 2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $24.53 | 2023 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $15.91 | 2023 | Flarex |
| Novartis Pharmaceuticals Corporation | $14.22 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.